ArticleTherapeutics and clinical risk management2011
Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture.
Jun Iwamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.